The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
The ‘cytokine profile’: a code for sepsis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A
Kabarowski, J. H. S., Zhu, K., Le, L. Q., Witte, O. N., & Xu, Y. (2001) · Science · doi:10.1126/science.1061781 · Cited by 332
RetractedAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Self-citationNicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., Li, J. H., Wang, H., Yang, H., Ulloa, L., et al. (2003) · Nature · doi:10.1038/nature01339 · Cited by 3,228
Self-citationShock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Self-citationMultiple Organ Dysfunction Score: A reliable descriptor of a complex clinical outcome
Marshall, J. C., Cook, D. J., Christou, N. V., Bernard, G. R., Sprung, C. L., & Sibbald, W. J. (1995) · Critical Care Medicine · doi:10.1097/00003246-199510000-00007 · Cited by 2,532
Cited by
Németh, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
“To determine whether nitric oxide might act through guanylyl cyclase in the BMSCs, we pretreated these cells with 1H-[1,2,4]oxadiazolo[4,3-a] quinoxalin-1-one (ODQ), an irreversible inhibitor of soluble guanylyl cyclase35 (Fig.”
Regulation of inflammation by short chain fatty acids
Vinolo, M. A. R., Rodrigues, H. G., Nachbar, R. T., & Curi, R. (2011) · Nutrients · doi:10.3390/nu3100858 · Cited by 1,724
Sepsis: pathophysiology and clinical management
Gotts, J. E., & Matthay, M. A. (2016) · BMJ · doi:10.1136/bmj.i1585 · Cited by 1,243
Animal Models of sepsis: setting the stage
Buras, J. A., Holzmann, B., & Sitkovsky, M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1854 · Cited by 843
Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation
Prockop, D. J., & Youn Oh, J. (2012) · Molecular Therapy · doi:10.1038/mt.2011.211 · Cited by 816
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
Schulte, W., Bernhagen, J., & Bucala, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/165974 · Cited by 745
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
Bozza, F. A., Salluh, J. I., Japiassu, A. M., Soares, M., Assis, E. F., Gomes, R. N., Bozza, M. T., Castro-Faria-Neto, H. C., & Bozza, P. T. (2007) · Critical Care · doi:10.1186/cc5783 · Cited by 740
Huston, J. M., Ochani, M., Rosas-Ballina, M., Liao, H., Ochani, K., Pavlov, V. A., Gallowitsch-Puerta, M., Ashok, M., Czura, C. J., Foxwell, B., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052362 · Cited by 683
Self-citationDopamine mediates vagal modulation of the immune system by electroacupuncture
Torres-Rosas, R., Yehia, G., Peña, G., Mishra, P., del Rocio Thompson-Bonilla, M., Moreno-Eutimio, M. A., Arriaga-Pizano, L. A., Isibasi, A., & Ulloa, L. (2014) · Nature Medicine · doi:10.1038/nm.3479 · Cited by 630
Self-citationThe alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
de Jonge, W. J., & Ulloa, L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707264 · Cited by 629
Self-citationFernandes, E. S., Passos, G. F., Medeiros, R., da Cunha, F. M., Ferreira, J., Campos, M. M., Pianowski, L. F., & Calixto, J. B. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.059 · Cited by 593
RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome
Duprez, L., Takahashi, N., Van Hauwermeiren, F., Vandendriessche, B., Goossens, V., Vanden Berghe, T., Declercq, W., Libert, C., Cauwels, A., & Vandenabeele, P. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.020 · Cited by 583
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*
Rice, T. W., Wheeler, A. P., Bernard, G. R., Vincent, J.-L., Angus, D. C., Aikawa, N., Demeyer, I., Sainati, S., Amlot, N., Cao, C., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e7c5c9 · Cited by 512
The vagus nerve and the nicotinic anti-inflammatory pathway
Ulloa, L. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1797 · Cited by 468
Self-citationImtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39506 · Cited by 461
Streptococcus Suis: A New Emerging or an Old Neglected Zoonotic Pathogen?
Gottschalk, M., Xu, J., Calzas, C., & Segura, M. (2010) · Future Microbiology · doi:10.2217/fmb.10.2 · Cited by 459
Molecular biology of inflammation and sepsis: A primer*
Cinel, I., & Opal, S. M. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819267fb · Cited by 387
Hypoxia-Inducible Factors as Essential Regulators of Inflammation
Imtiyaz, H. Z., & Simon, M. C. (2010) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2010_74 · Cited by 379
Liu, K., Mori, S., Takahashi, H. K., Tomono, Y., Wake, H., Kanke, T., Sato, Y., Hiraga, N., Adachi, N., Yoshino, T., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8770com · Cited by 366
High-mobility group box 1 (HMGB1) protein: Friend and foe
ULLOA, L., & MESSMER, D. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.01.003 · Cited by 341
Self-citationHMGB1: guiding immunity from within
Dumitriu, I. E., Baruah, P., Manfredi, A. A., Bianchi, M. E., & Rovere-Querini, P. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.009 · Cited by 340
Streptococcus suis infections in humans: the Chinese experience and the situation in North America
Gottschalk, M., Segura, M., & Xu, J. (2007) · Animal Health Research Reviews · doi:10.1017/s1466252307001247 · Cited by 329
Marshall, J. C., & Reinhart, K. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a02afc · Cited by 294
ELEVATED HIGH-MOBILITY GROUP BOX 1 LEVELS IN PATIENTS WITH CEREBRAL AND MYOCARDIAL ISCHEMIA
Goldstein, R. S., Gallowitsch-Puerta, M., Yang, L., Rosas-Ballina, M., Huston, J. M., Czura, C. J., Lee, D. C., Ward, M. F., Bruchfeld, A. N., Wang, H., et al. (2006) · SHOCK · doi:10.1097/01.shk.0000209540.99176.72 · Cited by 258
Self-citationα7-Cholinergic Receptor Mediates Vagal Induction of Splenic Norepinephrine
Vida, G., Peña, G., Deitch, E. A., & Ulloa, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003722 · Cited by 256
Self-citationNeutrophils in Periodontal Inflammation
Scott, D. A., & Krauss, J. (2012) · Frontiers of Oral Biology · doi:10.1159/000329672 · Cited by 254
JAK2 inhibition prevents innate immune responses and rescues animals from sepsis
Peña, G., Cai, B., Deitch, E. A., & Ulloa, L. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0628-z · Cited by 69
Self-citationLuan, Z.-G., Zhang, X.-J., Yin, X.-H., Ma, X.-C., Zhang, H., Zhang, C., & Guo, R.-X. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.04.013 · Cited by 59
Kobayashi, Y., Iwata, A., Suzuki, K., Suto, A., Kawashima, S., Saito, Y., Owada, T., Kobayashi, M., Watanabe, N., & Nakajima, H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222093110 · Cited by 59
Targeting HMGB1 TLR4 signaling as a novel approach to treatment of cerebral ischemia
Yang, Q.-W. (2010) · Frontiers in Bioscience · doi:10.2741/s119 · Cited by 55
Chelkeba, L., Ahmadi, A., Abdollahi, M., Najafi, A., Ghadimi, M. H., Mosaed, R., & Mojtahedzadeh, M. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0071-y · Cited by 51
“Saying in another way, it seems that the production and release of sepsis mediators should be considered as a network rather than as a cascade; consequently, once the process is started, even if one of the substances responsible for the initial phase is blocked, other mediators will likely maintain the septic response…”
BackgroundBuss, N. A. P. S., Gavins, F. N. E., Cover, P. O., Terron, A., & Buckingham, J. C. (2015) · The FASEB Journal · doi:10.1096/fj.14-268375 · Cited by 23
Metadata
- Authors
- Ulloa, L., & Tracey, K. J.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 11
- Issue
- 2
- Pages
- 56-63
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2035355922
- Cited by
- 440
- References
- 62
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.